1. The analgesic effect of ketorolac addition for renal colic pain: A meta-analysis of randomized controlled studies
- Author
-
Yan Yan-jun, Lin Hua, Nie Zhen, and Chen De-sheng
- Subjects
Adult ,Male ,Nausea ,Analgesic ,Cochrane Library ,law.invention ,03 medical and health sciences ,0302 clinical medicine ,Randomized controlled trial ,law ,medicine ,Humans ,Pain Management ,Renal colic ,Renal Colic ,Randomized Controlled Trials as Topic ,business.industry ,Anti-Inflammatory Agents, Non-Steroidal ,030208 emergency & critical care medicine ,General Medicine ,Middle Aged ,Ketorolac ,Anesthesia ,Meta-analysis ,Emergency Medicine ,Vomiting ,Drug Therapy, Combination ,Female ,medicine.symptom ,business ,medicine.drug - Abstract
Introduction The effect of ketorolac addition for the pain control of renal colic remains controversial. We conduct a systematic review and meta-analysis to explore the analgesic efficacy of ketorolac addition for renal colic. Methods We search PubMed, EMbase, Web of science, EBSCO, and Cochrane library databases through September 2020 for randomized controlled trials (RCTs) assessing the analgesic efficacy of ketorolac addition for renal colic. This meta-analysis is performed using the random-effect model. Results Four RCTs are included in the meta-analysis. In patients with renal colic pain, ketorolac addition is associated with significantly lower pain scores at 10–20 min (SMD=-2.50; 95% CI=-4.31 to −0.68; P=0.007) and analgesic rescue (RR=0.68; 95% CI=0.52 to 0.89; P=0.006), but reveals no notable effect on nausea (RR=0.36; 95% CI=0.12 to 1.12; P=0.08), vomiting (RR=0.50; 95% CI=0.13 to 1.95; P=0.31), or dizziness (RR=0.68; 95% CI=0.05 to 0.60; P=0.007). Conclusions Ketorolac addition may improve the analgesic efficacy for renal colic pain.
- Published
- 2021